Nuclera further reinforces finance team with new CFO

The company is accelerating protein expression and optimisation through its benchtop eProtein Discovery™ system and recently closed a $75 million funding round as it scales globally.

Now Seth Benson joins CEO Dr Michael Chen on the executive team to advance commercial and strategic initiatives, drive revenue and support expansion of the business. The company recently unveiled Bill Kullback, an experienced finance chief from California, as a non exec director.

Bringing extensive expertise in building operational and financial infrastructure, Benson will help steer Nuclera’s next phase of commercial expansion across key global markets.

With over 20 years of leadership experience in finance, strategy and operations in the life sciences and healthcare sectors, he is said to have a proven track record of scaling businesses, driving strategic growth, optimising operations and leading strategic financial initiatives.

He has successfully led fundraising efforts, acquisitions, restructurings and IPOs including at Akoya Biosciences where he helped grow the company to more than 300 people and played a pivotal role in its float.

Benson joins Nuclera from Vizgen, a company improving human health through spatial genomics, where he led the finance, operations and IT functions as CFO and guided the organisation through its acquisition of Ultivue, a spatial proteomics company.

Previously, as SVP Finance and Operations at Invaio Sciences, he managed a multinational finance team during early product commercialisation and fundraising. He has held investment banking positions at Morgan Stanley and Bank of America Merril Lynch.